Comparison Chart PharmaEssentia Corporation Deutsche Boerse AG

Stocks

8Z1

US7169722037

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG 03:34:57 2026-03-09 EDT			5-day change	1st Jan Change
15.50 ^EUR	-.--%		+11.00%	-

09-18	PharmaEssentia Gets Experts Board's Recommendation to Continue Phase 3 Myelofibrosis Drug Trial	MT
09-02	PharmaEssentia Receives FDA Approval For Ropeginterferon Alfa-2b-njft For Essential Thrombocythemia	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PHARMAESSENTIA CORPORATION	Bio Therapeutic Drugs	-.--%	+11.00%	-	-	-	15.17B	-	-	-